3rd Quarter - Report

W STRATEGIES, LLC for CALIFORNIA LIFE SCIENCES

Firm
Client
Income
$30,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Promoted life sciences community and communicated economic and health benefits of the industry.

LobbyistCovered position, as disclosed
DARREN WILLCOX —

Contacted: HOUSE OF REPRESENTATIVES

Taxation/Internal Revenue Code TAX

H.R. 2207: Protect Medical Innovation Act.

LobbyistCovered position, as disclosed
DARREN WILLCOX —

Contacted: HOUSE OF REPRESENTATIVES

Bills named: H.R. 2207 (116th)

Medicare/Medicaid MMM

Regulatory and legislative proposals in the Administrations Blueprint. H.R.2113: Prescription Drug STAR Act. H.R.2296: FAIR Drug Pricing Act. H.R.3: Lower Drug Costs Now Act of 2019.

LobbyistCovered position, as disclosed
DARREN WILLCOX —

Contacted: HOUSE OF REPRESENTATIVES

Bills named: H.R. 2113 (116th), H.R. 2296 (116th), H.R. 3 (116th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.